These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 36970154)

  • 1. Alzheimer's disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression.
    Meftah S; Gan J
    Front Synaptic Neurosci; 2023; 15():1129036. PubMed ID: 36970154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic dysfunction in early phases of Alzheimer's Disease.
    Pelucchi S; Gardoni F; Di Luca M; Marcello E
    Handb Clin Neurol; 2022; 184():417-438. PubMed ID: 35034752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Dickkopf-3, a Wnt antagonist elevated in Alzheimer's disease, restores synapse integrity and memory in a disease mouse model.
    Martin Flores N; Podpolny M; McLeod F; Workman I; Crawford K; Ivanov D; Leonenko G; Escott-Price V; Salinas PC
    Elife; 2024 Jan; 12():. PubMed ID: 38285009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for tau at the synapse in Alzheimer's disease pathogenesis.
    Pooler AM; Noble W; Hanger DP
    Neuropharmacology; 2014 Jan; 76 Pt A():1-8. PubMed ID: 24076336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model.
    Györffy BA; Tóth V; Török G; Gulyássy P; Kovács RÁ; Vadászi H; Micsonai A; Tóth ME; Sántha M; Homolya L; Drahos L; Juhász G; Kékesi KA; Kardos J
    Cell Mol Life Sci; 2020 Dec; 77(24):5243-5258. PubMed ID: 32034429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Mesenchymal Stem Cells in Regulating Astrocytes-Related Synapse Dysfunction in Early Alzheimer's Disease.
    Liu C
    Front Neurosci; 2022; 16():927256. PubMed ID: 35801178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal transcriptome, tau and synapse loss in Alzheimer's knock-in mice require prion protein.
    Stoner A; Fu L; Nicholson L; Zheng C; Toyonaga T; Spurrier J; Laird W; Cai Z; Strittmatter SM
    Alzheimers Res Ther; 2023 Nov; 15(1):201. PubMed ID: 37968719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-dimensional analysis of synaptic organization in the hippocampal CA1 field in Alzheimer's disease.
    Montero-Crespo M; Domínguez-Álvaro M; Alonso-Nanclares L; DeFelipe J; Blazquez-Llorca L
    Brain; 2021 Mar; 144(2):553-573. PubMed ID: 33324984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.
    Wu M; Zhang M; Yin X; Chen K; Hu Z; Zhou Q; Cao X; Chen Z; Liu D
    Transl Neurodegener; 2021 Nov; 10(1):45. PubMed ID: 34753506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic Dysfunction in Alzheimer's Disease: Aβ, Tau, and Epigenetic Alterations.
    Li K; Wei Q; Liu FF; Hu F; Xie AJ; Zhu LQ; Liu D
    Mol Neurobiol; 2018 Apr; 55(4):3021-3032. PubMed ID: 28456942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology progression.
    Pizzirusso G; Preka E; Goikolea J; Aguilar-Ruiz C; Rodriguez-Rodriguez P; Vazquez-Cabrera G; Laterza S; Latorre-Leal M; Eroli F; Blomgren K; Maioli S; Nilsson P; Fragkopoulou A; Fisahn A; Arroyo-García LE
    Brain Behav Immun; 2024 Jul; 119():286-300. PubMed ID: 38608739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synapse as a treatment avenue for Alzheimer's Disease.
    Peng L; Bestard-Lorigados I; Song W
    Mol Psychiatry; 2022 Jul; 27(7):2940-2949. PubMed ID: 35444256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease.
    Guerrero-Muñoz MJ; Gerson J; Castillo-Carranza DL
    Front Cell Neurosci; 2015; 9():464. PubMed ID: 26696824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain.
    Kurbatskaya K; Phillips EC; Croft CL; Dentoni G; Hughes MM; Wade MA; Al-Sarraj S; Troakes C; O'Neill MJ; Perez-Nievas BG; Hanger DP; Noble W
    Acta Neuropathol Commun; 2016 Mar; 4():34. PubMed ID: 27036949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the neuronal synapse and challenges associated with the mitochondrial dysfunction in mild cognitive impairment and Alzheimer's disease.
    Verma H; Gangwar P; Yadav A; Yadav B; Rao R; Kaur S; Kumar P; Dhiman M; Taglialatela G; Mantha AK
    Mitochondrion; 2023 Nov; 73():19-29. PubMed ID: 37708950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
    Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F
    J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer's Disease.
    Yin X; Qiu Y; Zhao C; Zhou Z; Bao J; Qian W
    Med Sci Monit; 2021 Sep; 27():e933084. PubMed ID: 34471085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and synapse turnover in Alzheimer's disease.
    Dalal S; Ramirez-Gomez J; Sharma B; Devara D; Kumar S
    Ageing Res Rev; 2024 Aug; 99():102377. PubMed ID: 38871301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.